BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.67 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.